ArticleP & T : a peer-reviewed journal for formulary management2018

Valbenazine (Ingrezza): The First FDA-Approved Treatment for Tardive Dyskinesia.

Stepan Uhlyar et al.PubMed ↗Full text ↗

No numbers read from the abstract.